CD177 and viral infectious disease: Therefore, the outcomes of the viral infection vary according to the vigor of the immune response, a process that is regulated by several molecules, including the cell surface receptor CTLA-4 [64], which is consistent with its emerging role in the T regulatory cells in the pathogenesis of the disease.